News

Biotech firm attracts $29 million in 2nd funding round. Spaltudaq

March 17, 2007/

Seattle-based Spaltudaq http://www.spaltudaq.com/ started out as one man in a lab with an idea for fighting cancer.

Now it’s scored $29 million in its second round of venture-capital funding, a shot in the arm that should carry the biotech company into its first round of clinical trials.

By Kirsten Orsini-Meinhard

Seattle Times business reporter

Full Story: http://seattletimes.nwsource.com/html/businesstechnology/2003622556_spaltudaq17.html

Related Stories

No related posts.

Leave a Comment

You must be logged in to post a comment.

MATR Sponsor (view all)


"For small to medium to national organizations, for events and fundraisers of any size, in any format – live, virtual or hybrid – the platform is built for scale."

MATR Supporters (view all)


Working closely with GFDA’s economic development team, HPF helps Montana businesses access the capital they need to expand, modernize, and strengthen local communities.

Make Your Future in the College of Business

ADROIT Employer Resources is a Montana-based workforce and talent solutions partner